If a drug with high hepatic extraction is administered orally but shows unexpectedly high bioavailability, which mechanism explains this observation?

💡 Explanation

High hepatic extraction typically results in low oral bioavailability due to the first-pass effect. However, if the drug bypasses the liver, it avoids this initial metabolism. Therefore, bypassing the hepatic first-pass effect will lead to higher bioavailability, rather than changes in renal, tubular, or biliary clearance mechanisms.

• Why does thyroid hormone (TH) production often remain stable despite variations in thyrotropin-releasing hormone (TRH) from the hypothalamus?
• A long-distance runner experiences a stress fracture in their tibia. Which biomechanical mechanism, resulting from repetitive loading, best explains the bone remodeling failure?
• Why does digoxin, a drug with a narrow therapeutic index, exhibit variable plasma concentrations between patients even when administered at the same weight-normalized dose?
• Why does cellular dysfunction persist after the acute phase of a concussion, despite apparent macroscopic brain recovery?
• A patient with a persistent bacterial infection develops Guillain-Barré syndrome. Which mechanism explains this autoimmune response targeting peripheral nerves?
• Why does the nervous system often struggle to distinguish between chronic pain and acute pain following peripheral nerve sensitization?